| Secondary |
| Insomnia |
25.2% |
| Depression |
18.4% |
| Product Used For Unknown Indication |
8.2% |
| Hypertension |
7.6% |
| Drug Use For Unknown Indication |
5.9% |
| Suicide Attempt |
4.2% |
| Constipation |
3.9% |
| Cardiac Failure Chronic |
3.6% |
| Angina Pectoris |
3.0% |
| Gastritis |
2.5% |
| Intentional Overdose |
2.2% |
| Multiple Drug Overdose Intentional |
2.2% |
| Cardiac Failure |
2.1% |
| Prophylaxis |
1.8% |
| Diabetes Mellitus |
1.8% |
| Crohn's Disease |
1.6% |
| Sleep Disorder |
1.6% |
| Colon Cancer Metastatic |
1.4% |
| Hyperuricaemia |
1.4% |
| Diarrhoea |
1.3% |
|
| Suicide Attempt |
15.4% |
| Hepatitis Fulminant |
10.7% |
| Tremor |
8.1% |
| Interstitial Lung Disease |
6.0% |
| Somnolence |
6.0% |
| Hepatic Encephalopathy |
4.0% |
| Sepsis |
4.0% |
| Swollen Tongue |
4.0% |
| Toxic Epidermal Necrolysis |
4.0% |
| Vomiting |
4.0% |
| Bradyphrenia |
3.4% |
| Hepatic Enzyme Increased |
3.4% |
| Hepatic Function Abnormal |
3.4% |
| Loss Of Consciousness |
3.4% |
| Overdose |
3.4% |
| Pneumonia |
3.4% |
| Premature Rupture Of Membranes |
3.4% |
| Sopor |
3.4% |
| Stevens-johnson Syndrome |
3.4% |
| Syncope |
3.4% |
|
| Concomitant |
| Insomnia |
15.9% |
| Prophylaxis |
10.8% |
| Product Used For Unknown Indication |
10.3% |
| Hypertension |
9.2% |
| Drug Use For Unknown Indication |
8.4% |
| Constipation |
6.3% |
| Depression |
6.3% |
| Rheumatoid Arthritis |
4.2% |
| Hepatitis C |
4.1% |
| Gastritis |
3.2% |
| Pain |
3.0% |
| Diabetes Mellitus |
3.0% |
| Chronic Hepatitis C |
2.8% |
| Cancer Pain |
2.4% |
| Schizophrenia |
2.2% |
| Osteoporosis |
1.7% |
| Hiv Infection |
1.7% |
| Bipolar Disorder |
1.5% |
| Cardiac Failure |
1.5% |
| Metastatic Renal Cell Carcinoma |
1.4% |
|
| White Blood Cell Count Decreased |
11.9% |
| Pyrexia |
7.9% |
| Rash |
7.2% |
| Vomiting |
7.0% |
| Interstitial Lung Disease |
6.4% |
| Pneumonia |
5.2% |
| Renal Impairment |
5.2% |
| Hepatic Function Abnormal |
4.8% |
| Liver Disorder |
4.7% |
| Suicide Attempt |
4.7% |
| Sepsis |
4.5% |
| White Blood Cell Count Increased |
4.3% |
| Rhabdomyolysis |
4.1% |
| Tremor |
4.1% |
| Malaise |
4.0% |
| Platelet Count Decreased |
3.0% |
| Thrombocytopenia |
2.9% |
| Drug Eruption |
2.7% |
| Death |
2.6% |
| Nausea |
2.6% |
|
| Interacting |
| Bronchopulmonary Aspergillosis |
39.0% |
| Diabetes Mellitus |
19.5% |
| Product Used For Unknown Indication |
19.5% |
| Dementia |
12.2% |
| Aspergillosis |
4.9% |
| Pyrexia |
4.9% |
|
| Hiccups |
38.5% |
| Liver Disorder |
38.5% |
| Sudden Death |
15.4% |
| Thrombosis |
7.7% |
|
